The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B

Blood Advances
J Michael SoucieUS Hemophilia Treatment Center Network

Abstract

Data are needed on minimal factor activity (FA) levels required to prevent bleeding in hemophilia. We aimed to evaluate associations between hemophilia type and FA level and joint bleeding and orthopedic procedures using longitudinal data. Data were collected over an 11-year period on males with nonsevere hemophilia A or B without inhibitors who were receiving on-demand factor replacement therapy. Data on the number of joint bleeds in the previous 6 months and data on procedures from clinical records were analyzed using regression models. Data were collected on 4771 patients (hemophilia A, 3315; hemophilia B, 1456) from 19 979 clinic visits. Ages ranged from 2 to 91 years and baseline FA level ranged from 1% to 49% with a mean of 9.4%. Joint bleeding rates were heterogeneous across the FA range and were highest among men age 25 to 44 years. Adjusted for FA level, the mean number of joint bleeds per 6 months was 1.4 and 0.7 for patients with hemophilia A and B, respectively (P < .001). Regression models predicted 1.4 and 0.6 bleeds per year for hemophilia A and B patients, respectively, at an FA level of 15%. Patients with hemophilia B were 30% less likely than those with hemophilia A to have undergone an orthopedic procedure. W...Continue Reading

References

May 3, 2000·Haemophilia : the Official Journal of the World Federation of Hemophilia·J A AznarJ M Tusell
Sep 30, 2000·Haemophilia : the Official Journal of the World Federation of Hemophilia·C A LudlamG D Lowe
Sep 1, 2005·Haemophilia : the Official Journal of the World Federation of Hemophilia·K van DijkH M van den Berg
Sep 21, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·M RichardsC Rothschild
Jul 22, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·T T BissUNKNOWN Canadian Association of Nurses in Hemophilia Care (CANHC)
Dec 8, 2009·Blood·Ingrid E M den UijlKathelijn Fischer
Apr 2, 2010·American Journal of Preventive Medicine·J Michael SoucieYing Su
Apr 2, 2010·American Journal of Preventive Medicine·John H DrakeBrenda Riske
Sep 10, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·I E M den UijlI Plug
Feb 24, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·K NagelM K Pai
Jun 29, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·Mark W Skinner
Mar 23, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·P M Mannucci, M Franchini
Jun 15, 2013·Journal of Thrombosis and Haemostasis : JTH·M Escobar, S Sallah
Oct 22, 2013·Trends in Genetics : TIG·Alister P W Funnell, Merlin Crossley
Feb 19, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·D M Di MicheleA Ganguly
Jun 5, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·N ClausenUNKNOWN PedNet and Research of Determinants of Inhibitor development (RODIN) Study Group
Jul 26, 2014·Journal of Thrombosis and Haemostasis : JTH·V S BlanchetteA Srivastava
Feb 12, 2017·Blood·Marilyn J Manco-JohnsonUNKNOWN Joint Outcomes Committee of the Universal Data Collection, US Hemophilia Treatment Center Network
Aug 25, 2017·Journal of Thrombosis and Haemostasis : JTH·M J Manco-JohnsonW Hong
Dec 7, 2017·The New England Journal of Medicine·Lindsey A GeorgeKatherine A High
Dec 12, 2017·The New England Journal of Medicine·Savita RangarajanK John Pasi

❮ Previous
Next ❯

Citations

Jan 4, 2019·Haemophilia : the Official Journal of the World Federation of Hemophilia·Glenn F PierceUNKNOWN Members of the WFH Gene Therapy Round Table Program Committee and Organizing Committee
Apr 9, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Antony P MartinJamie O'Hara
Jul 24, 2020·Current Opinion in Hematology·Ming Y Lim, Tyler W Buckner
Aug 26, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Silvia LinariGiancarlo Castaman
Sep 10, 2020·The New England Journal of Medicine·Barbara A KonkleCraig C Benson
Oct 1, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Céline RowJulien Bovet
Dec 29, 2018·British Journal of Haematology·Susan Shapiro, Mike Makris
Mar 27, 2020·Research and Practice in Thrombosis and Haemostasis·Fabienne KloostermanKarin Fijnvandraat
Sep 3, 2020·Journal of Thrombosis and Haemostasis : JTH·Amal AbdiUNKNOWN INSIGHT Study Group
Apr 24, 2019·Research and Practice in Thrombosis and Haemostasis·Barbara A KonkleAlfonso Iorio
Aug 31, 2020·Research and Practice in Thrombosis and Haemostasis·Michael WangJ Michael Soucie
Aug 10, 2020·Current Gene Therapy·Miaojin ZhouDesheng Liang
Feb 2, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Christopher WalshDavid L Cooper
Feb 2, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Michelle WitkopDavid L Cooper
Apr 10, 2021·Journal of Blood Medicine·Richard GoodingPratima Chowdary
Nov 14, 2020·Blood Reviews·Robert F SidonioStacy E Croteau
May 25, 2021·Research and Practice in Thrombosis and Haemostasis·Erna C van BalenSamantha C Gouw
Jun 25, 2021·Biologics : Targets & Therapy·Emanuela MarchesiniLeonard Valentino
Jul 9, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·C LaurendeauB Detournay
Aug 17, 2021·Current Opinion in Hematology·Peter H Cygan, Peter A Kouides
Sep 30, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·John Puetz, Dunlei Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.